Two-Year Outcomes of Anticoagulation for Acute Ischemic Stroke With Nonvalvular Atrial Fibrillation ― SAMURAI-NVAF Study ―Sohei Yoshimura, Kazumi Kimura, Yoshiki Yagita et al.|Circulation Journal|2018Cited by 44
Prior Anticoagulation and Short‐ or Long‐Term Clinical Outcomes in Ischemic Stroke or Transient Ischemic Attack Patients With Nonvalvular Atrial FibrillationKeisuke Tokunaga, Masato Osaki, Masatoshi Koga et al.|Journal of the American Heart Association|2019Cited by 17
Early Achievement of Blood Pressure Lowering and Hematoma Growth in Acute Intracerebral Hemorrhage: Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement-Intracerebral Hemorrhage StudyYoshitaka Yamaguchi, Masatoshi Koga, Shoichiro Sato et al.|Cerebrovascular Diseases|2018Cited by 12
Clinical characteristics and prognosis of ischemic stroke/transient ischemic attack patients with non-valvular atrial fibrillation not eligible for large trials of direct oral anticoagulants: SAMURAI-NVAF studyM. Kumamoto, Ḱazunori Toyoda, Shunsuke Sato et al.|Journal of the Neurological Sciences|2017Cited by 0
Supplementary Material for: Early Achievement of Blood Pressure Lowering and Hematoma Growth in Acute Intracerebral Hemorrhage: Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement-Intracerebral Hemorrhage StudyYoshitaka Yamaguchi, For The SAMURAI Study Investigators, Masatoshi Koga et al.|Figshare|2018Cited by 0